Loading…
Vir Biotechnology, Inc. is projected to rise to $12.72 by 2027, a +28% move from its current price of $9.96. VIR is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $9.69 | $9.96 | $10.24 | +0.01% |
| Jul 14 | $9.58 | $9.96 | $10.36 | +0.03% |
| Jul 15 | $9.49 | $9.96 | $10.46 | +0.04% |
| Jul 16 | $9.42 | $9.97 | $10.54 | +0.06% |
| Jul 17 | $9.36 | $9.97 | $10.61 | +0.07% |
| Jul 18 | $9.31 | $9.97 | $10.67 | +0.08% |
| Jul 19 | $9.26 | $9.97 | $10.74 | +0.10% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $9.26 | $9.97 | $10.74 | +0.10% |
| Week 2 | $8.99 | $9.98 | $11.08 | +0.20% |
| Week 3 | $8.79 | $9.99 | $11.35 | +0.30% |
| Week 4 | $8.62 | $10.00 | $11.59 | +0.40% |
| Week 5 | $8.48 | $10.01 | $11.81 | +0.49% |
| Week 6 | $8.36 | $10.02 | $12.01 | +0.59% |
| Week 7 | $8.25 | $10.03 | $12.20 | +0.69% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline targets hepatitis delta virus (HDV) and other solid tumors.
The company’s preclinical candidates include those targeting influenza A and B antibodies and antibody drug conjugates, and coronavirus monoclonal antibodies; and PRO-XTEN, a dual-masked TCEs targeting variety of solid tumors. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.
It maintains grant collaboration and license agreements with Astellas; license agreement with Norgine for the treatment of CHD; amended and restated letter agreement with the Gates Foundation; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreement with the Institute for Research in Biomedicine; a license agreement with The Rockefeller University; license agreements with Xencor; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A.
Vir Biotechnology, Inc. (VIR) is currently priced at $10.16 and has a market capitalization of $1.71B. It is ranked 2148 by market cap. The price outlook from the forecast shows an upward path with rising averages and bullish sentiment prevailing in most years.
The stock’s near-term technical picture remains constructive, supported by key moving averages and defined support/resistance levels.
A major floor 26.0% below — a decisive break under it would weaken the trend.
The nearest floor, 17.2% below — buyers have tended to step in here.
The nearest ceiling, 4.7% above — a clean break opens room to run.
A major ceiling 17.7% above — clearing it would confirm fresh momentum.
Key VIR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of VIR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $10.20 | Sell | $10.14 | Sell |
| MA 10 | $10.12 | Sell | $10.05 | Sell |
| MA 20 | $9.68 | Buy | $9.80 | Buy |
| MA 50 | $9.40 | Buy | $9.50 | Buy |
| MA 100 | $9.39 | Buy | $9.06 | Buy |
| MA 200 | $7.80 | Buy | $8.30 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 53.92 | Neutral |
| Stoch RSI (14) | 15.07 | Buy |
| CCI (20) | 34.20 | Neutral |
| Williams %R (14) | -54.02 | Info |
| MACD (12,26,9) | 0.04 | Buy |
| ROC (12) | -1.97 | Sell |
| Bollinger %B (20,2) | 0.61 | Neutral |
| Stochastic %K (14) | 45.98 | Neutral |
| TRIX (15) | 0.38 | Buy |
| Awesome (5,34) | 0.82 | Buy |
| Ultimate (7,14,28) | 50.01 | Neutral |
| Momentum (10) | 0.08 | Buy |
| Aroon Osc (25) | 72.00 | Buy |
| Hull MA (9) | 10.34 | Sell |
| ADX (14) | 16.91 | Neutral |
| ATR (14) | 0.26 | Info |
The 30-day technical picture shows a range from $8.30 to $12.44. RSI14 is 60, indicating moderate momentum. SMA50 is $9.49 and SMA200 is $7.50, with the current price of $10.16 sitting above both averages. The near-term support is $8.25 and the resistance is $10.16.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $5.79 | $9.96 | $12.90 | 0% | Neutral | |
| $10.11 | $12.72 | $16.96 | +28% | Bullish | |
| $10.28 | $13.31 | $18.42 | +34% | Bullish | |
| $10.71 | $14.21 | $20.26 | +43% | Bullish | |
| $11.06 | $14.98 | $21.90 | +50% | Bullish | |
| $11.54 | $15.93 | $23.79 | +60% | Bullish | |
| $13.00 | $18.27 | $27.82 | +83% | Bullish | |
| $14.82 | $21.18 | $32.82 | +113% | Bullish | |
| $16.81 | $24.41 | $38.44 | +145% | Bullish | |
| $17.85 | $26.31 | $42.06 | +164% | Bullish | |
| $24.37 | $38.51 | $65.54 | +287% | Bullish | |
| $39.57 | $70.45 | $131.37 | +607% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $5.79 | $9.96 | $11.93 | +0.00% |
| August 2026 | $8.36 | $9.87 | $11.98 | -0.86% |
| September 2026 | $8.48 | $10.09 | $12.38 | +2.17% |
| October 2026 | $8.65 | $10.36 | $12.83 | +2.67% |
| November 2026 | $8.51 | $10.23 | $12.78 | -1.20% |
| December 2026 | $8.48 | $10.25 | $12.90 | +0.16% |
Click any year to see its month-by-month VIR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The VIR price prediction for 2026 points to an average of $9.96 (low $5.79, high $12.90) — a potential gain of 0% on today's $9.96. Price action looks broadly range-bound.
In 2027, VIR is projected to trade between $10.11 and $16.96, averaging $12.72 — a potential gain of +28% from today's $9.96. That is up +28% on the projected 2026 average. Buyers look set to stay in control over this stretch.
Vir Biotechnology, Inc.'s 2028 outlook centres on $13.31, within a $10.28 to $18.42 range. That is up +5% on the projected 2027 average. That marks a +34% change versus current levels. Momentum favours further upside here.
By 2029, VIR could reach as high as $20.26, with a base case around $14.21 and support toward $10.71 — roughly +43% from $9.96. Buyers look set to stay in control over this stretch.
Expect VIR to range from $11.06 to $21.90 through 2030. The $14.98 average target implies a +50% move from current prices. That is up +5% on the projected 2029 average. Momentum favours further upside here.
The VIR price prediction for 2031 points to an average of $15.93 (low $11.54, high $23.79) — a potential gain of +60% on today's $9.96. Buyers look set to stay in control over this stretch.
In 2032, VIR is projected to trade between $13.00 and $27.82, averaging $18.27 — a potential gain of +83% from today's $9.96. That is up +15% on the projected 2031 average. Momentum favours further upside here.
Vir Biotechnology, Inc.'s 2033 outlook centres on $21.18, within a $14.82 to $32.82 range. That is up +16% on the projected 2032 average. That marks a +113% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, VIR could reach as high as $38.44, with a base case around $24.41 and support toward $16.81 — roughly +145% from $9.96. Momentum favours further upside here.
Expect VIR to range from $17.85 to $42.06 through 2035. The $26.31 average target implies a +164% move from current prices. That is up +8% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The VIR price prediction for 2040 points to an average of $38.51 (low $24.37, high $65.54) — a potential gain of +287% on today's $9.96. Momentum favours further upside here.
In 2050, VIR is projected to trade between $39.57 and $131.37, averaging $70.45 — a potential gain of +607% from today's $9.96. That is up +83% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in VIR today (≈ 100.401606 VIR) could be worth
$7,073.49
+$6,073.49 (+607%) by 2050 · US Dollar
Based on the average projected VIR price of $70.45 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in VIRwould be worth at today's price.
$1,000 invested in VIR on Jul 10, 2025 (≈ 168.634069 VIR) would be worth
$1,679.6
+$679.6 (+68.0%) today · 1.68× · US Dollar
Based on a VIR entry price of $5.93 vs. today's $9.96.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $10.04 | $992.03 | -0.8% |
| 1 month ago | $8.25 | $1,207.27 | +20.7% |
| 3 months ago | $9.5 | $1,048.42 | +4.8% |
| 6 months ago | $5.92 | $1,682.43 | +68.2% |
| 1 year ago | $5.93 | $1,679.6 | +68.0% |
| All time (5.0y) ago | $36.25 | $274.76 | -72.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our VIR forecast.
Our base-case forecast reaches $20.00 around 2033.
Implied market cap at $20.00: $3.37B
The multi-year forecast paints a bullish trajectory with rising average prices and expanding ROIs. For 2026 the avg is $10.16 with neutral sentiment, then 2027 avg $13.49 (ROI 32.8%, bullish), 2028 avg $13.72 (ROI 35.1%, bullish), 2029 avg $15.27 (ROI 50.3%, bullish), 2030 avg $16.30 (ROI 60.4%, bullish), 2031 avg $17.02 (ROI 67.5%, bullish), 2032 avg $20.77 (ROI 104.4%, bullish), 2033 avg $24.17 (ROI 137.9%, bullish), 2034 avg $27.44 (ROI 170.1%, bullish), 2035 avg $30.79 (ROI 203%, bullish), 2040 avg $45.35 (ROI 346.4%, bullish), and 2050 avg $86.06 (ROI 747.1%, bullish). These figures imply a steady rise in expected value over time, with sentiment turning bullish in 2027 and persisting through 2050.
Tap a question to reveal the answer.
Avg $16.30; min $11.81; max $24.33; ROI 60.4%; sentiment BULLISH.
The forecast shows a path of rising averages with bullish sentiment from 2027 onward and higher ROIs, such as 60.4% in 2030 and 747.1% in 2050, though 2026 is neutral and the figures are estimates.
The 2050 forecast max is $166.52, which means reaching $100 is within the projected range by 2050; earlier years show lower max values (e.g., 2040 max $79.65).
Current price is $10.16 and market cap is $1.71B.
Avg $45.35; min $27.62; max $79.65; ROI 346.4%; sentiment BULLISH.
Vir Biotechnology, Inc. Community Discussion
0Share your Vir Biotechnology, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.